US declares monkeypox a national health emergency, as new drugmakers consider entering vaccine race
Rising monkeypox cases have put the US on high alert as it announces a national health emergency, which grants the government more power in its response.
The news comes as Bavarian Nordic continues to fill orders for its Jynneos vaccine and other companies – including Moderna – consider jumping into the vaccine race. Meanwhile, the New York Times reports that the US has allowed around 20 million doses of smallpox vaccine in its stockpile to expire.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.